Reuters - Video

エディション: US | UK | IN | CN | JP

video

Bayer profit flat as weak animal health offsets strong Xarelto

2018年 11月 13日 Tuesday - 01:29

Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales. Sonia Legg reports.

▲ ストーリーを隠す

ストーリーを表示する

Bayer's adjusted core earnings were flat for the quarter, as better prescription numbers for cardiovascular drug Xarelto were tempered by a weaker animal health business and a strong euro weighing on the value of overseas sales. Sonia Legg reports.

リンクをコピーするには:URL上で右クリック後「コピー」を選択。モバイル端末では、URLを長押ししてください。

Bayer profit flat as weak animal health offsets strong Xarelto

2018年 11月 13日 Tuesday - 01:29